AI TRADING

AI Robots

MOST POPULAR

Stocks & ETFs, MFs & FOREX

AI Real Time Patterns

Forex

Patterns (one at a time)

Stocks & ETFs & FOREX

INVESTING

CREATE & TRACK

AI Portfolio Wizards for Beginners

Stocks & ETFs, MFs & FOREX

AI Portfolio Manager

Stocks & ETFs, MFs & FOREX

DISCOVER & FOLLOW

401(k) Portfolios & Reports

Paper Trades Exchange

COMMUNITY

Find your way Market Summary Dashboard What`s new AI Robots 1-on-1 lessons Help Sale

DNLI

TRADE

AS OF

May 1, 02:08 PM (EDT)

Price

$16.02

Change

+$0.58 (+3.76%)

Capitalization

2.2B

One day until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

DNLI is expected to report earnings to rise+18.35% to -70 cents per share on May 02

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

05/01/24

DNLI - Denali Therapeutics

Q1'24

Est.

$-0.70

Q4'23

Missed

by $0.06

Q3'23

Beat

by $0.09

Q2'23

Beat

by $1.99

Q1'23

Missed

by $0.09

The last earnings report on December 31 showed earnings per share of -86 cents, missing the estimate of -80 cents. P/B Ratio (2.135) is normal, around the industry mean (10.139). P/E Ratio (0.000) is within average values for comparable stocks, (115.202). DNLI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.468). DNLI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (6.418) is also within normal values, averaging (226.762). With 969.51K shares outstanding, the current market capitalization sits at 2.20B.

View a ticker or compare two or three

Compare

DNLI